Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Share-based Compensation (2023 - 2025)

Bioregenx (BRGX) has 1 years of Share-based Compensation data on record, last reported at -$1.4 million in Q4 2024.

  • For Q4 2024, Share-based Compensation changed N/A year-over-year to -$1.4 million; the TTM value through Sep 2025 reached -$1.4 million, down 190.95%, while the annual FY2024 figure was $135056.0, 93.97% down from the prior year.
  • Share-based Compensation reached -$1.4 million in Q4 2024 per BRGX's latest filing, down from $802264.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.7 million in Q1 2024 and bottomed at -$1.4 million in Q4 2024.